BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16264436)

  • 1. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral acyclic nucleoside phosphonates structure activity studies.
    Holý A
    Antiviral Res; 2006 Sep; 71(2-3):248-53. PubMed ID: 16857275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral drug discovery and development: where chemistry meets with biomedicine.
    De Clercq E
    Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.
    De Clercq E
    Antiviral Res; 2007 Jul; 75(1):1-13. PubMed ID: 17116336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
    De Clercq E
    Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short synthesis and antiviral activity of acyclic phosphonic acid nucleoside analogues.
    Liu LJ; Yoo JC; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2009 Feb; 28(2):150-64. PubMed ID: 19219742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
    Fu XZ; Jiang SH; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral evaluation of novel cyclopropyl nucleosides, phosphonate nucleosides and phosphonic acid nucleosides.
    Hyun Oh C; Hong JH
    Arch Pharm (Weinheim); 2006 Sep; 339(9):507-12. PubMed ID: 16795106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.
    De Clercq E
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):21-43. PubMed ID: 15482100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.
    Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2003 Nov; 46(23):5064-73. PubMed ID: 14584956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    Intervirology; 1997; 40(5-6):295-303. PubMed ID: 9675635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Holý Trinity: the acyclic nucleoside phosphonates.
    De Clercq E
    Adv Pharmacol; 2013; 67():293-316. PubMed ID: 23886004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position.
    Krecmerová M; Masojídková M; Holý A
    Bioorg Med Chem; 2010 Jan; 18(1):387-95. PubMed ID: 19914075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 5-substituted 2'-deoxyuridine-5'- phosphonate analogues and evaluation of their antiviral activity.
    Poecke SV; Sinnaeve D; Martins JC; Balzarini J; Calenbergh SV
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):256-72. PubMed ID: 22356239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral evaluation of novel exomethylene acyclic nucleosides and phosphonic acid nucleosides.
    Kim A; Hong JH
    Arch Pharm (Weinheim); 2005 Nov; 338(11):528-33. PubMed ID: 16281311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates.
    Topalis D; Pradère U; Roy V; Caillat C; Azzouzi A; Broggi J; Snoeck R; Andrei G; Lin J; Eriksson S; Alexandre JA; El-Amri C; Deville-Bonne D; Meyer P; Balzarini J; Agrofoglio LA
    J Med Chem; 2011 Jan; 54(1):222-32. PubMed ID: 21128666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.
    De Clercq E
    Med Res Rev; 2013 Nov; 33(6):1278-303. PubMed ID: 23568857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters.
    Romanowska J; Szymańska-Michalak A; Boryski J; Stawiński J; Kraszewski A; Loddo R; Sanna G; Collu G; Secci B; La Colla P
    Bioorg Med Chem; 2009 May; 17(9):3489-98. PubMed ID: 19282192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of chemical stability of antivirally active 5-azacytosine acyclic nucleoside phosphonates using NMR spectroscopy.
    Dracínský M; Krecmerová M; Holý A
    Bioorg Med Chem; 2008 Jul; 16(14):6778-82. PubMed ID: 18554916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
    De Clercq E
    Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.